Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Fiona Powrie was one of four researchers from the University of Oxford recognised for their outstanding contributions to immunology with Honorary Lifetime Membership of the British Society for Immunology.

Fiona Powrie receives an Honorary Lifetime Membership of the British Society for Immunology at the BSI Congress
Fiona Powrie receives an Honorary Lifetime Membership of the British Society for Immunology at the BSI Congress

Fiona Powrie, Director of the Kennedy Institute was awarded honorary membership in recognition of her contributions to the field of immunology, including her seminal work on regulatory T cells and pioneering gut immunology research. The awards were announced at the recent British Society for Immunology Congress held in Edinburgh.

Professors Dame Sarah Gilbert, Teresa Lambe, and Sir Andrew Pollard received the awards for developing the ChAdOx1 nCoV-19 coronavirus vaccine, and all four have inspired scores of new immunologists in the field.

Fiona said: 'As an immunologist it is particularly special to be recognised by my colleagues with Lifetime Membership of the British Society for Immunology. I have been a member of the BSI since I started my training and benefited then from the science and networking opportunities as do members of my lab today.'

Professors Gilbert, Lambe and Pollard also accepted the Global Impact and Innovation Award in recognition of all those involved in the design and development of the ChAdOx1 nCoV-19, including the scientists, support staff and clinical trial volunteers.

Professor Teresa Lambe OBE, Head of Vaccine Immunology at the Oxford Vaccine Group, said: 'It is an honour to be recognised with this award from my fellow immunologists, but in particular I was humbled to accept the award on behalf of the teams who have worked across the ChAdOx1 nCoV-19 vaccine development here at Oxford, whose efforts have been integral to seeing this vaccine developed in record time, with over 2 billion doses now released worldwide.'

 

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.